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Abstract: It has now been known for over a decade that low frequency ultrasound can be used to effectively enhance 
transdermal drug penetration - an approach termed sonophoresis. Mechanistically, acoustic cavitation results in the crea-
tion of defects in the stratum corneum that allow accelerated absorption of topically applied molecules. The aim of this 
study was to develop an optimised sonophoresis protocol for studying transdermal drug delivery in vitro. To this end, caf-
feine was selected as a model hydrophilic drug while porcine skin was used as a model barrier. Following acoustic valida-
tion, 20kHz ultrasound was applied for different durations (range: 5 s to 10 min) using three different modes (10%, 33% 
or 100% duty cycles) and two distinct sonication procedures (either before or concurrent with drug deposition). Each ul-
trasonic protocol was assessed in terms of its heating and caffeine flux-enhancing effects. It was found that the best regi-
men was a concurrent 5 min, pulsed (10% duty cycle) beam of SATA intensity 0.37 W/cm
2. A key insight was that in the 
case of pulsed beams of 10% duty cycle, sonication concurrent with drug deposition was superior to sonication prior to 
drug deposition and potential mechanisms for this are discussed.  
Keywords: Transdermal, Sonophoresis, Caffeine, Drug delivery, Optimised, Pig skin. 
INTRODUCTION 
Although ultrasound has been used by physiotherapists 
since the 1950s [1], it only since the mid-1990s that low fre-
quency ultrasound (20 to 150 kHz) has been identified as 
an effective means of enhancing transdermal drug delivery. 
Such an application of low frequency ultrasound is termed 
sonophoresis [2-5]. 
Over the last decade, considerable research has been di-
rected towards understanding the parameters and paradigms 
that modulate sonophoresis. Mechanistically, it is known that 
acoustically-induced cavitation results in the formation of 
intercellular lipid channels and defects in the stratum cor-
neum. These perturbations allow accelerated cutaneous in-
gress of solutes [6-8]. The extent of enhancement is deter-
mined by four principal acoustic variables - frequency, in-
tensity, duty cycle, and duration. In general, enhancement 
increases with decreasing ultrasound frequency and this is 
due to the fact that ultrasound induces proportionally more 
cavitational activity at lower frequencies. Transport en-
hancement also increases with increasing intensity although 
two thresholds, both a lower cut-off intensity and upper de-
coupling intensity, may occur [9]. Lengthening the duration 
of application or using a greater duty cycle in the case of 
pulsed ultrasound (ie increasing the “pulse-on” time) will 
similarly tend to increase enhancement. 
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Although the fundamental biophysical processes are now 
understood, it is still difficult to predict the extent of drug 
delivery enhancement produced by any given application of 
low frequency ultrasound. This is due to the fact that the 
extent of cavitational disordering of the stratum corneum 
depends upon numerous factors such as the; transducer to 
skin distance, transducer geometry as well as the availability 
and distribution of dissolved gas. Furthermore, the thermal 
effects of ultrasound may also act as a secondary contributor 
to transport enhancement [10]. This is a further confounding 
variable since tissue heating is difficult to predict as it is de-
pendent upon many interactive variables, some of which 
exhibit positive feedback processes. Additionally, a consid-
erable proportion of studies have used electrical resistance 
measurements as a surrogate marker of skin permeability 
[11-13] thus resulting in a relative scarcity of real permeabil-
ity data within the context of sonophoresis. 
The aim of the present study was to develop a suitable 
protocol that could be used to directly measure sonophoretic 
drug delivery in vitro and to determine the relative contribu-
tion of ultrasound parameters in low-frequency ultrasound-
induced percutaneous enhancement of drug transport. For 
this purpose, caffeine was chosen as a model hydrophilic 
drug while full thickness porcine skin was used as a barrier 
membrane. After initial acoustic source validation studies, 
20kHz ultrasound was applied for different durations (range: 
5 s to 10 min) using three different modes (10%, 33% and 
100% duty cycles) and two distinct sonication procedures 
(either prior to or concurrent with drug deposition). Each 
ultrasonic treatment was assessed in terms of its skin surface 
heating and caffeine permeation-enhancing effects. The ob-Development of an Optimised Application Protocol  The Open Biomedical Engineering Journal, 2011, Volume 5    15 
jective was to identify the most optimal application regimen. 
Investigations were also conducted with respect to the effect 
of ultrasound on caffeine stability as well as on epidermal 
structure as imaged by electron microscopy.  
MATERIALS AND METHODS 
Materials 
Caffeine, HPLC-grade acetonitrile, phosphate buffer sa-
line tablets (pH 7.4), glutaraldehyde, osmium tetraoxide 2% 
w/v solution, potassium dihydrogen orthophosphate and 
disodium hydrogen orthophosphate were purchased from 
Sigma-Aldrich (Poole, UK).  HPLC grade glacial acetic acid 
was obtained from Fisher Scientific (Loughborough, UK) 
while absolute ethanol was purchased from Bamford Labs 
(Rochdale, UK).  Double-distilled water was used through-
out. 
Validation of the Ultrasound Source 
Low frequency (20kHz) ultrasound was generated by a 
VCX-500 ultrasound processor (Sonics & Materials; New-
town CT) connected to a 3mm diameter transducer probe. 
Since it is sometimes the case that the actual acoustic output 
may not match the manufacturer’s specified values [14, 15], 
it was necessary to initially validate the processor’s acoustic 
dosimetry. 
Frequency measurements were undertaken using a cali-
brated hydrophone (B&K 8103, Stevenage, UK) directly 
connected to an Infiniium oscilloscope (Agilent, Woking-
ham, UK) operating at 500MHz and 2GSa/s. However, even 
at the lowest possible intensity setting, the emitted ultra-
sound produced sufficient cavitation to interfere with the 
operation of the hydrophone. This problem was overcome by 
controlling the processor via an external DC voltage source 
connected through a 9-pin D-type socket. This procedure 
allowed the minimal acoustic energy to be reduced by 75%, 
which facilitated effective hydrophone use. Subsequently, 
both the transducer tip and hydrophone were immersed in a 
5-litre tank filled with distilled water. Acoustic pressure os-
cillations were measured at a distance of 5 cm from the 
transducer face. 
The acoustic intensity emitted by the probe could, in the-
ory, be obtained by performing a simple procedure specified 
by the manufacturer. Briefly, this involved adjusting the 
processor’s amplitude dial to a selected value (range: 21 to 
40%) and subsequently reading off the power monitor read-
ings when the probe was operating in distilled water and then 
in air. The difference between the two monitor readings was 
divided by the transducer area in order to obtain the manu-
facturer’s intensity value. In order to validate these values, 
we employed a simple calorimetric method. To this end, the 
transducer was immersed in a Dewar-type (Dilvac
®) ther-
moflask (VWR, Lutterworth, UK), filled with 500ml of dis-
tilled water. The ultrasound probe was immersed into the 
water and continuous wave ultrasound was applied for 15 
minutes at different amplitude settings. Water temperatures 
were measured both before and after sonication. The experi-
ment was conducted in triplicate. The following equation 
was used to yield the Spatial-Average Temporal-Average 
(SATA) intensity output: 
 
The final validation study involved use of a laser vi-
brometer (Polytec GmbH, Waldbronn, Germany) to measure 
the mechanical vibrations of the transducer’s active face [16, 
17]. The transducer was isolated from the VCX500 instru-
ment and electrically excited using a HP 33120A Arbitrary 
Function Generator (AFG). A 20 kHz sinusoidal signal of 
peak-to-peak amplitude 10V was generated using the AFG to 
ensure that the probe did not produce a cavitating field when 
recording the experimental measurements. In addition, the 
AFG provided a synchronisation pulse to trigger the laser 
vibrometry measurement system. Importantly, the surface 
vibration characteristic can be used to evaluate the ultrasonic 
pressure field using Hygen’s Principle [17]. This information 
can be used to determine the position of any cavitating field 
through analysis of the pressure maxima [18]. 
Preparation of Skin Membranes 
Porcine ears (Landrace species) were obtained from a lo-
cal abattoir immediately after slaughter of the animals but 
before steam sterilisation of the tissue. The ears were cleaned 
under cold running water. The external surface of each ear 
was sectioned horizontally by scalpel to yield whole skin 
samples, of area 8cm
2. The skin sections were visually 
checked for integrity then stored in a frozen state (-80°C) for 
a maximum period of 3 months [19]. This storage condition 
had shown no significant effect on Kp as a result of freezing 
as shown [20, 21]. Immediately prior to the permeation stud-
ies, the porcine skin sections were thawed at room tempera-
ture and cut into smaller samples (surface area 1cm
2) suit-
able for mounting on Franz cells. 
Transdermal Permeation Studies 
The full-thickness skin samples were mounted in Franz 
diffusion cells (PermeGear, Bethlehem PA), exhibiting a 
diffusion-available surface area of 0.64 cm
2 and a receptor 
compartment volume of 5.3 ml. The receptor solution con-
sisted of PBS (pH 7.4) that had been previously degassed by 
5 min exposure to 35 kHz ultrasound in a Transsonic T310 
water bath sonicator (Camlab Ltd, Cambridge UK). This 
receiver solution was stirred at 600rpm and maintained at 37 
± 0.5°C by the use of a thermostatic water pump (Haake 
DC10, Karlsruhe, Germany) that circulated water through 
each chamber jacket. The skins were initially allowed to hy-
drate in the Franz cells for 1 hour. During this period, the 
Franz cells were occasionally inverted in order to allow the 
escape of any air bubbles that had developed on the skin 
underside. Subsequently, 0.5ml of 0.5% w/v caffeine solu-
tion in PBS (pH 7.4) was deposited on to each skin surface. 
Apart from during periods of ultrasonication or thermocou-
ple insertion, the donor compartments were always covered 
with a taut layer of Parafilm
 in order to minimise evapora-
tion. 
Caffeine permeation was allowed to proceed for a total 
period of either 24 h or 48 h, depending upon the length of 
the lag time. At selected time intervals, a 100μl aliquot of 
receiver solution was withdrawn from each receiver solution 
and replaced with the same volume of blank PBS solution. 
Permeant amounts in the withdrawn solutions were deter-
mined by HPLC. The caffeine concentration values derived 16    The Open Biomedical Engineering Journal, 2011, Volume 5  Sarheed and Abdul Rasool 
for each aliquot were corrected for the progressive dilutions 
occurring during the course of the experiment, as described 
previously [22, 23]. Each individual experiment consisted of 
between 6 to 8 replicate runs. 
Ultrasonication Protocols 
Two types of ultrasound exposure protocols were em-
ployed – pretreatment and concurrent applications. 
For pretreatment experiments, sonication was undertaken 
immediately after hydration of the skin but prior to the topi-
cal application of the caffeine-containing solution. This step 
involved the deposition of 0.5 ml of PBS (pH 7.4) in each 
donor compartment. The transducer, aligned perpendicular to 
the skin surface, was immersed in this solution with its ac-
tive tip face located 5 mm above the skin surface. The skin 
was then exposed to different ultrasound treatment regimens 
with the spatial- average temporal-peak (SATP) intensity 
fixed at 3.7W/cm
2. Application of continuous wave ultra-
sound was conducted for a total duration of either 0s (con-
trol), 5s, 30s, 120s, or 600s.  Application of pulsed ultra-
sound in 1s on: 2s off mode (33% duty cycle) was conducted 
for a total duration of 30s or 120s. The application of ultra-
sound in 1s on: 9s off mode (10% duty cycle) was also per-
formed over 300s or 1200s. 
For concurrent ultrasound studies, sonication was under-
taken immediately after topical deposition of the caffeine-
containing solution. The transducer was clamped into posi-
tion in the same manner as described above and activated 
using the same duration-mode combinations listed above.  
Skin surface temperature measurements were undertaken 
during the course of each ultrasound application. These 
measurements were conducted with a HI 8757 microproces-
sor-controlled thermometer (Hanna instruments Ltd., 
Leighton Buzzard, UK).  
Contribution of Thermal Effects to Sonophoretic-
Enhanced Transport  
To differentiate between the thermal and the non-thermal 
effects on the drug transport, heat treatment was used to 
compare with the ultrasound treated group. Permeation ex-
periments were performed by replacing the ultrasound trans-
ducer by an electrical resistance connected to an AC genera-
tor. The electrical power delivered by the generator was con-
trolled to reproduce the temperature versus time profile of 
the donor solution observed during sonication for 5 min. The 
temperature closed to the skin would be heated and raised 
most greatly to 42.6°C. Generally-speaking it is believed that 
45ºC is a cut-off temperature beyond which irreversible 
changes occur in the skin [24].  
Caffeine Stability Studies 
The aim of these experiments was to determine whether 
ultrasonic exposure degrades caffeine. For this purpose, 
0.5ml aliquots of 0.5% w/v caffeine solution in PBS (pH 7.4) 
were deposited on porcine skin samples mounted on Franz 
cells. Each donor solution was sonicated for 600s with con-
tinuous wave energy at an intensity of 3.7 W/cm
2. Each topi-
cal solution was assayed for caffeine by HPLC both before 
and after sonication. The experiment was performed in trip-
licate. 
HPLC Assay 
Analysis of caffeine samples was performed on a HPLC 
system (Finnigan SpectraSystem
, ThermoElectron Corp.) 
equipped with a solvent degasser (Model SCM1000), an 
autosampler (Model AS3000) and UV photodiode array de-
tector (Model 6000). Samples were eluted on a C18-
Phenomenex
 column (150mm x 4.6mm; 5μm) using a mo-
bile phase consisting of consisting of 0.05M acetic acid: ace-
tonitrile (90:10). The elution parameters were a flow rate of 
1ml/min and an injection volume of 20μl. The detection 
wavelength was 272nm. Calibration of the system was 
achieved through the use of external standards. The analyti-
cal parameters for this assay were as follows: retention time 
was 5.5 minutes, limit of detection was 0.5μg/ml, and repro-
ducibility relative standard deviation was 2%.  
Scanning Electron Microscopy 
Electron microscopy was used to visualise the effect of a 
concurrent 300s pulsed ultrasound (10% duty cycle) applica-
tion on epidermal structure. In order to achieve this, whole 
porcine skin samples were mounted in Franz cells, treated 
with caffeine solution and subjected to this sonication regi-
men in the manner described above (sections 2.4 and 2.5). 
Other skin samples were subjected to a control treatment that 
involved topical caffeine solution deposition but no ultra-
sound application. At 1 hour after caffeine application, the 
skin samples were removed from the diffusion cells and a 
scalpel was used to excise tissue strips of dimensions 1mm 
x 2mm from the central area of each sample. 
The first stage of fixation involved immersing the skin 
strips for 1 hour at room temperature in a solution of 2.5% 
glutaraldehyde in 0.1M phosphate buffer (pH 7.4). Subse-
quently, the samples were transferred to a temperature-
controlled room maintained at 4ºC where they were im-
mersed overnight in 0.1M of phosphate buffer. Each skin 
section was then washed three times with 0.1M of phosphate 
buffer. A 1% buffered solution of osmium tetraoxide was 
prepared by mixing, at a 1:1 ratio, an aqueous solution of 2% 
w/v osmium tetraoxide with 0.05M phosphate buffer. The 
skin samples were immersed in this buffer for 1 hour at room 
temperature. Each skin sample was then serially washed six 
times with distilled water in order to remove excess residues 
of osmium tetraoxide.  
Progressive dehydration of the skin was undertaken at 
room temperature. To this end, the skin strips were initially 
washed for one minute in 30% aqueous ethanol and then 
washed for a further minute in 50% aqueous ethanol. Subse-
quently, the tissues were immersed in 70% aqueous alcohol 
for one hour, 90% aqueous alcohol for 10 minutes and fi-
nally absolute alcohol for 10 minutes. The samples were 
dried in a model CPD750 critical point dryer (Emscope, 
Ashford, UK). The dried specimens were gold-coated on a 
K575X Peltier-cold stage sputter-coater (Emitech, Ashford, 
UK). Specimens were then observed under a Philips 500 
scanning electron microscope (Eindhoven, Netherlands) us-
ing a 3kV or 6kV accelerating voltage. Photographs were 
taken of suitably representative skin regions. Development of an Optimised Application Protocol  The Open Biomedical Engineering Journal, 2011, Volume 5    17 
RESULTS  
Validation of the Ultrasound Source 
Hydrophone measurements confirmed that the acoustic 
frequency was constant at 19.88 kHz, which is just 0.6% 
below the manufacturer’s indicated value. With respect to 
intensity, Fig. (1) shows that there was a good linear correla-
tion (r
2 = 0.993) between the measured intensity values and 
the manufacturer’s intensity values. Yet from the equation 
shown in Fig. (1), the calorimetrically-measured intensities 
were somewhat lower (18%) than that specified by the 
manufacturer hence providing evidence for the necessity of 
validation in this type of study.  
Fig. (2a) illustrates the experimentally measured surface 
displacement characteristic across the probe surface, as im-
aged using laser vibrometry. It can be seen that despite some 
spatial variability, the active transducer face exhibited a rela-
tively homogenous surface displacement magnitude. Moreo-
ver, the corresponding phase characteristic demonstrated that 
the transducer behaviour was close to the desired piston-like 
operation (data not shown). By extrapolating this data [17] 
the pressure field distribution generated by the probe was 
 
Fig. (1). Acoustic intensity calibration plot for the VCX-500 ultrasonic processor. Error bars represent standard deviation values; n=3. 
 
Fig. (2). The surface displacement characteristics of the active transducer tip in terms of: (a) Magnitude, (b) Details of predicted acoustic 
pressure field close to probe tip. The x and y axes represent spatial dimensions (arbitrary values). 
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evaluated. Fig. (2b) illustrates that the high intensity region 
is in close proximity to the probe tip. 
Ultrasound Effect on Caffeine Stability 
It was found that exposing topical caffeine solution to 
continuous wave ultrasound at 3.7 W/cm
2 for 600s did not 
cause any drug degradation (Fig. 3a  and b ).  The HPLC 
method showed a recovery percentage of 100%. Since this 
represented the maximal energy used in our experiments, we 
could exclude the possibility of caffeine degradation occur-
ring in the present study. 
Transport Data 
Continuous Wave Ultrasound 
Fig. (4) shows the influence of continuous wave ultra-
sound application on the steady state permeation of caffeine 
through full thickness skin. It can be seen that in the absence 
of ultrasound, the mean kp was 11.7 x 10
-4 cm/h. This is very 
close to the mean value of 13.6 x 10
-4 cm/h that we have 
measured previously in our lab for passive caffeine transport 
[22]. These figures are somewhat higher than the kp value of 
2.5 x 10
-4 cm/h recorded by [25] for caffeine transport across 
full-thickness pig ear skin. Differences in vehicle composi-
 
 
Fig. (3). Caffeine stability chromatograms shows the effect of continuous wave ultrasound for 600s at 3.7 W/cm
2 (a) before ultrasound expo-
sure and (b) after ultrasound exposure (n=3). 
 
Fig. (4). The influence of continuous wave ultrasound on the transdermal permeability of caffeine. Black columns indicate concurrent ultra-
sound exposure while diagonal pattern columns indicate ultrasound pre-treatment. Error bars represent S.E.M. values, n  6. * indicates sig-
nificantly different from control as determined by t-test (P  0.05). 
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tion, experimental conditions as well as porcine species may 
explain this discrepancy. 
In the current study, concurrent application of ultrasound 
for periods of 5, 30, 120 or 600s resulted in an approximate 
doubling of transdermal caffeine permeation, although the 
effect was only statistically significant for the two lengthiest 
applications. Sonication for 0, 5, 30, 120 and 600s resulted in 
mean skin surface temperatures of 31.0ºC, 31.7 ºC, 37.5ºC, 
39.6ºC and 43.0ºC being attained immediately after sonica-
tion at these respective time points. It should be noted that 
attenuation can result in much greater heating occurring in 
the underlying skin layers. Hence, these surface temperatures 
may underestimate the total extent of tissue heating. 
In the ultrasound pre-treatment studies, sonication for 5, 
30, 120 and 600s enhanced steady state caffeine permeation 
in comparison to passive permeation by 1.9, 3.4, 3.1 and 1.5-
fold respectively (Fig. 4). These enhancement effects were 
statistically significant except for the 600s application, which 
was in significant (P  0.05). Sonication for 0, 5, 30, 120 and 
600s resulted in respective mean skin surface temperatures 
of 31.0ºC, 31.8ºC, 37.5 ºC, 45.2ºC and 57.2ºC being attained 
immediately after irradiation. Hence, ultrasound pre-
treatment produced greater heating of skin than the same 
duration of concurrently applied ultrasound. This may be due 
to the absence of dissolved caffeine in the solution and / or 
that these solutions were degassed before being used in the 
transport studies. Either of these factors can influence the 
rate of acoustic attenuation in the solution-filled donor com-
partment.  
Pulsed Ultrasound with a 33% Duty Cycle 
Fig. (5) shows the influence of pulsed ultrasound applica-
tions (33% duty cycle) on steady state cutaneous transport of 
caffeine. The graphs show that concurrent sonication for 90s 
and 360s increased the mean kp by 1.3 times and 2.09 times 
respectively. Of these, only the lengthier application pro-
duced significantly increased permeation enhancement. Im-
mediately after 90s and 360s of ultrasonication, skin surface 
temperatures were 35.3 ± 0.8 ºC and 39.5 ± 2.2ºC respec-
tively.  
For the ultrasound pre-treatment approach, 90s and 360s 
of sonication enhanced caffeine permeation by 1.4-fold and 
1.78-fold respectively. Again, only the kp elevation induced 
by the greater duration was statistically significant. Skin sur-
face temperatures immediately following sonication were 
34.4 ± 0.9 ºC and 37.2 ± 1.9 ºC respectively. 
Pulsed Ultrasound with a 10% Duty Cycle 
Fig. (6) depicts the effects of pulsed ultrasound (10% 
duty cycle) on transcutaneous caffeine delivery. Concurrent 
application of ultrasound for 300s yielded a significant 3.88-
fold increase in mean caffeine permeability, relative to con-
trol conditions. This 300s application resulted in a post-
sonication skin surface temperature of 33.9 ± 0.7ºC. A 
lengthier sonication period of 1200s yielded a significant 
3.03-fold enhancement in drug permeability and was associ-
ated with a final temperature of 34.1 ± 0.7 ºC at the skin sur-
face.  
Use of the pre-treatment method for 300s produced an in-
significant 2.27-fold enhancement in mean caffeine perme-
ability, relative to passive conditions. This was associated 
with a skin surface temperature of 33.7 ± 0.6 ºC when the 
ultrasound was switched off. Increasing the ultrasound dura-
tion to 1200s induced a significant 1.92-fold elevation in 
caffeine permeation. The post-sonication skin temperature 
was 34.2 ± 0.5 ºC. 
Selection of an Optimal Sonication Protocol 
Table 1 lists all the tested sonication regimens that pro-
duced significant increases in caffeine permeation while not 
elevating skin surface temperatures beyond 5ºC over the 
control levels (31ºC). It can be seen that the 10% pulsed 
beam applied concurrently with caffeine treatment over 300s 
yielded a 3.88-fold enhancement in drug transport coupled 
 
Fig. (5). The influence of pulsed ultrasound (33% duty cycle) on transdermal caffeine permeability. Black columns indicate concurrent ultra-
sound exposure while diagonal pattern columns indicate ultrasound pre-treatment. Error bars represent S.E.M. values, n  6. * indicates sig-
nificantly different from control as determined by t-test (P  0.05). 
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with a temperature elevation of only 2.9ºC. The combination 
of a relatively brief application period, high enhancement 
ratio and moderate heating makes this regimen probably op-
timal for performing sonophoretic delivery studies. The Spa-
tial-average temporal-average (SATA) intensity of this 
beam, given by multiplying the SATP intensity value by the 
duty cycle, was 0.37 W/cm
2. Fig. (7) presents the full cumu-
lative penetration time plot for this selected sonication proto-
col. Interestingly, ultrasonication did not greatly affect the 
lag time. 
Contribution of Thermal Effects to Sonophoretic-
Enhanced Transport  
To separate out the thermal contribution of US applica-
tion to the enhancement of transdermal delivery it was nec-
essary to investigate the thermal effect of sonophoresis via 
temperature control as prescribed in the methods section. 
The caffeine transport results are summarized in Fig. (8). 
Clearly, sonophoresis at 20 kHz (concurrent; 300s; 10% duty 
cycle), and at an intensity of 0.37 W/cm
2 as well as heat 
alone significantly enhances skin permeability by 3.88 times 
and 1.60 times respectively. However, the temperature ‘con-
trol’ experiment revealed that ~40% of this improvement 
could be attributed solely to a thermal effect. The figure is 
somewhat higher than the thermal contribution value of 
~25% reported by Merino G et al. [10]. Differences in drug 
and vehicle composition, experimental conditions as well as 
porcine species may explain this discrepancy. 
Morphological Effects 
Fig. (9) shows an electron micrograph-derived surface 
view of human skin, 1 hour after deposition of the topical 
caffeine solution. It can be seen that without ultrasonication, 
the corneocytes on the skin surface remained relatively flat, 
intact and confluent. However, application of the selected 
sonication regimen (concurrent; 300s; 10% duty cycle) 
caused the corneocytes to become partially detached from 
each other and develop defects and tears. Additionally, it 
appears that the entire layer of corneocytes has been lifted up 
and undergone considerable disordering (Fig. 10). 
DISCUSSION 
Screening of the different sonication regimens showed 
that each application produced differential heating and caf-
feine flux enhancement effects. As previously mentioned, 
 
Fig. (6). The influence of pulsed ultrasound (10% duty cycle) on the transdermal permeability of caffeine. Black columns indicate concurrent 
ultrasound while diagonal pattern columns indicate ultrasound pre-treatment. Error bars represent s.e.m. values, n  6. * indicates signifi-
cantly different from control as determined by t-test (P  0.05). 
 
Table 1. Permeabilising Sonication Regimens that Produced Significant Increases in Caffeine Permeation 
Application 
Total Duration 
(s) 
Duty Cycle 
(%) 
Mean Temperature Rise (ºC)  Enhancement Ratio 
Pretreatment 5  100  0.8  1.90 
Pretreatment 90  33  4.3  1.78 
Concurrent 300  10  2.9  3.88 
Concurrent 1200  10  3.1  3.03 
Pretreatment 1200  10  3.2  1.92 
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the magnitude of these phenomena would have been notori-
ously difficult to predict from theory due to the complex and 
interactive nature of the multiple variables involved. 
Out of all the tested sonication protocols, we found that 
the best was a 300s, concurrently-applied, pulsed (10% duty 
cycle) output with a SATA intensity of 0.37 W/cm
2. This 
regimen was optimal for performing sonophoretic drug de-
livery studies as it was relatively brief, induced minimal skin 
heating yet produced an almost 4-fold increase in steady 
state caffeine flux. Barrier permeabilisation was due to per-
turbation of the stratum corneum, probably mostly induced 
by acoustic cavitation. However, in vivo, the stratum cor-
neum is likely to recover as the underlying viable epidermal 
cells would undergo upward movement and desquamation. 
A highly positive aspect of our selected sonication proto-
col was its brief duration. In an important study, Boucaud 
and co-workers [26, 27] also used a 20kHz output with a 
10% duty cycle and found that this beam facilitated a 3.73-
fold increase in caffeine permeation across dermatomed hu-
man skin. However, this was achieved by using a SATA 
intensity of 2.5W/cm
2 and sonicating for a full hour. Others 
[28] experimented with continuous wave 40kHz ultrasound 
exhibiting a SATA intensity of 0.44 W/cm
2 (SATA) and 
reported a 3.81-fold increase in in vitro caffeine flux across 
hairless mouse skin. Although ultrasonication did not elevate 
skin temperature, the application lasted for 5 hours. Clearly, 
it is desirable to develop an in vitro transdermal delivery 
system that involves ultrasound application lasting several 
 
Fig. (7). The effect of 300s of concurrently-applied pulsed ultrasound (10% duty cycle) on the cumulative permeation of caffeine across por-
cine skin. Empty and filled squares denote passive and sonophoretic conditions, respectively. Error bars represent S.E.M. values, n  6. 
 
Fig. (8). The effect of 300s of concurrently-applied pulsed ultrasound (10% duty cycle) and heat alone on the transdermal caffeine perme-
ability across porcine skin. Error bars represent S.E.M. values, n  6. 
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minutes rather than hours as this will have greater clinical 
relevance. 
Interestingly, in the case of exposure to beams with a 
10% duty cycle, both concurrent applications were more 
permeabilising than the pre-treatment applications of the 
same duration (See Fig 6). The differences were significant 
for sonication for 300s (t-test: P=0.006) and for sonication 
for 1200s (t-test: P=0.005). There are two potential explana-
tions for this. One possibility is that the cavitational-induced 
microstreaming and mixing is necessary in order to allow for 
maximal caffeine flux through ultrasonically-compromised 
stratum corneum. In other words, acoustic cavitation not 
only produces defects in the stratum corneum but also cre-
ates secondary microcurrents that further accelerate drug flux 
through these defects. An alternative mechanism relates to 
the fact that the stratum corneum exhibits some elasticity 
[29]. It is possible that after the ultrasound is switched off, at 
least some of the cavitationally-induced pores partially close 
over (Prof Richard Guy: personal communication). Either or 
both of these explanations would explain why the concurrent 
application was superior to pre-application for 10% pulsed 
beams. It is also possible that the time between sonication 
and drug application in the pretreatment application may 
influence on the efficiency of drug transport through the 
skin. However, this is an area needs to be further investi-
gated.  
It is noteworthy that in the case of the 33% and 100% 
duty cycle beams, there was no consistent difference in 
sonophoretic efficacy between the pre-treatment and concur-
rent regimens. This is likely due to the fact that these beams 
produced large and variable heating effects. Such thermal 
components of skin permeabilisation would tend to mask 
those due to cavitation.  In contrast, for all four 10% duty 
cycle beams, skin surface temperature elevations were con-
sistently small (between 2.7ºC to 3.2ºC) as the skin cooled 
during the relatively lengthy “ultrasound off” times.  
The skin permeability enhancement induced by sonopho-
resis can be attributed to both thermal and nonthermal effects 
[30]. To clarify the root of permeability a control tempera-
 
Fig. (9). Representative surface view of porcine skin (original magnification x1000) (a) at 1 hour after deposition of topical caffeine solution 
and (b) at 24 hour after deposition of topical caffeine solution. 
 
Fig. (10). Representative surface view of porcine skin (original magnification x 500) after deposition of topical caffeine solution with con-
current exposure to pulsed ultrasound (10% duty cycle) for 300s. (a) At 1 hour after treatment (b) at 24 hour after treatment. Development of an Optimised Application Protocol  The Open Biomedical Engineering Journal, 2011, Volume 5    23 
ture experiment was conducted which revealed ~40% of skin 
enhancement could be caused due to the increase in tempera-
ture.  
Additionally the skin permeability increased significantly 
(p  0.05) almost 2 times when heated to 42.6 °C (10 °C 
increase). The literature supports the observation and sug-
gests that for every 10 °C increase in temperature leads to 
doubling of skin permeability [31].  
However, it is evident that the enhancement effect of 
sonophoresis goes beyond that provoked by a simple tem-
perature increase; alternatively cavitation is proposed to be 
main mechanism for skin enhancement [26, 27].  
CONCLUSIONS 
Our study showed that the most practical regimen for 
sonophoretic drug delivery was a concurrent 5 min, pulsed 
(10% duty cycle) beam exhibiting a SATA intensity of 0.37 
W/cm
2. Although conveniently brief, this application pro-
duced minimal skin heating yet facilitated a 3.88-fold in-
crease in steady state caffeine flux. In more general terms, 
we determined that pulsed ultrasound with a 10% duty cycle 
could be just as efficacious for sonophoretic delivery as ul-
trasound of greater duty cycles. Furthermore, for beams ex-
hibiting a 10% duty cycle, sonication concurrent with drug 
deposition was more effective than sonication prior to drug 
deposition. This last aspect may be of particular importance 
in the development and testing of novel sonophoretic deliv-
ery systems. For further research, it would noteworthy to 
study if there is an optimal sonophoretic protocol can be 
generalized into similar hydrophilic and/or lipophilic drug 
molecules. Also further studies will be necessary to deter-
mine the relative contribution of temperature and time pa-
rameters in sonophoretic induced- percutaneous enhance-
ment of drug transport. 
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